PM360

OCTOBER 28, 2022

Promising AI Use Cases in Pharma. Although we’re still at the beginning of the AI revolution in pharma, promising use-cases have already been identified: Drug discovery: In drug discovery , AI models are predicting the 3D structure of target proteins at an unprecedented scale. in 2010 to only 1.9%

Pharma 105

Pharma Food and Drug Administration Medicine Government 105

pharmaphorum

OCTOBER 31, 2022

A recent Morgan Stanley Research report suggested that even modest improvements in early-stage drug development success rates with AI and machine learning could lead to an additional 50 novel therapies over a 10-year period, and translate to a $50 billion-plus market opportunity. Alice Zhang.

Pharma 136

Pharma Leads Medicine Marketing 136

Pharmaceutical Technology

NOVEMBER 21, 2022

Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio. The post Warnings for Japanese pharmaceutical market may lead to more lenient price controls appeared first on Pharmaceutical Technology.

Marketing 69

Marketing Pharmaceutical Leads Manufacturing 69

PM360

MARCH 5, 2025

As a CEO who successfully engineered two billion-dollar pharma transactions [2] with AstraZenca and Novo Nordisk during COVID-19 when many organizations struggled to keep the lights on [3], what are the top skills which aspiring CEOs need to secure as they pursue their career aspirations?

Engineering 52

Engineering Management Consulting Education 52

pharmaphorum

JULY 13, 2022

The alliance sees Bicycle and Genentech collaborate on the discovery and preclinical testing of bicyclic peptides, with the Roche company taking over after a lead drug candidate is selected for further development. Roche isn’t the only big pharma partner Bicycle has attracted for its bicyclic peptide technology.

Leads 106

Leads Manufacturing Pharma 106

PM360

AUGUST 12, 2024

CineHealth brings discussion about content and storytelling from key industry thought leaders to leading healthcare conference. Veteran CINEHEALTH judge and General Hospital actor Maurice Benard will be keynoting Digital Pharma East. It is organized by the Fierce Pharma editorial and conference teams at Fierce Pharma, part of Questex.

Pharma 59

Pharma Media Networking Education 59

pharmaphorum

OCTOBER 28, 2022

In 2018, she was nominated by Pharmaceutical Marketing Europe as one of the 30 most influential women in UK Healthcare, and in September 2019 appointed by the UK’s Chief Scientific Officer to be an Ambassador for Women in Science and Engineering (WISE). She is an SME in market access, rare disease and biosimilars.

Medicine 122

Medicine Management Marketing Leads 122

Pharmaceutical Technology

NOVEMBER 21, 2022

Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio. The post Warnings for Japanese pharmaceutical market may lead to more lenient price controls appeared first on Pharmaceutical Technology.

Pharmaceutical 52

Pharmaceutical Leads Marketing Manufacturing 52

European Pharmaceutical Review

FEBRUARY 21, 2023

After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. He founded Celadon in 2018. Prior to leading the firm McKinsey, Arthur was an M&A investment banker at Lazard. There is huge potential for new licensed drugs in the space.

Medicine 132

Medicine Manufacturing Specialization Pharmaceutical 132

European Pharmaceutical Review

APRIL 27, 2023

The pharma company’s current CEO and Chairman of the Board Dr Giovanni Caforio will retire on November 1 2023. He has served as EVP, Chief Commercialization Officer since August 2018. Theodore R Samuels will continue to serve as Lead Independent Director. Dr Caforio will continue as Executive Chairman of the Board.

Medicine 94

Medicine Marketing Government Leads 94

pharmaphorum

OCTOBER 5, 2022

billion deal in 2018. ” Financial terms of the agreement have also not been disclosed, but from a logistical perspective TrialSpark will take the lead on clinical development, in consultation with Sanofi. The aim will be to identify promising candidates in areas of “unmet patient need.”

Biopharma 105

Biopharma Engineering Consulting Pharma 105

European Pharmaceutical Review

AUGUST 14, 2023

Swedish pharmaceutical company Vicore Pharma is developing treatments for diseases where the angiotensin II type 2 receptor (AT2R) has a central role in stopping and reversing disease pathology and where there is a large unmet medical need. The company’s lead candidate, C21, is an angiotensin II type 2 receptor agonist (ATRAG).

Pharma 98

Pharma Side effects Patients Manufacturing 98

pharmaphorum

JULY 9, 2014

IMS Health forecasts the global market will see a compound average growth rate of between 4 to 7 percent in constant dollar terms to 2018, driven by two very different speed growth engines: at best low single digit value growth in the developed markets, contrasting with largely double digit growth in the power house pharmerging markets.

Marketing 52

Marketing Digital Media Pharma Engineering 52

Pharmaceutical Technology

JANUARY 22, 2023

In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. However, while only around 34% of the approvals in 2018 were for orphan drugs, 54% new approvals in 2022 were for drugs to treat rare diseases. This was not always the case. “Up A major symptom of MCT8 deficiency is an overexpression of T3.

FDA 126

FDA Safety Pharmaceutical Patients 126

Pharmaceutical Technology

MARCH 1, 2023

Venture financing for early-stage innovator drugs for biotech companies based in the Asia-Pacific (APAC) region between 2018 to 2022 received three times less funding, at $23bn, than their US counterparts, at $72bn, according to GlobalData’s Pharma Intelligence Centre Deals Database.

Pharma 72

Pharma Marketing Biopharma Pharmaceutical 72

pharmaphorum

SEPTEMBER 29, 2022

Patient insights are now vital to the full spectrum of pharma – to the full continuum of research to HTA, pricing, and reimbursement. This can contribute to a scattergun approach in which findings are not collated, leading to duplicated efforts that waste time and resources for organisations, PAGs, and patients alike.

Patients 98

Patients Food and Drug Administration Medicine Pharma 98

Clarivate

AUGUST 2, 2022

The CIRS study found that the FDA approved the highest number of NASs in 2021, continuing its streak of being the leading NAS approver since 2017. Compared to all NASs approved between 2018 and 2021, NASs approved via the Access Consortium had shorter roll out times, which was largely due to lower submission gaps (Figure 2).

Medicine 98

Medicine Food and Drug Administration FDA Healthcare 98

Clarivate

FEBRUARY 28, 2023

Degeneration of the retinal ganglion cells causes rapidly progressing vision loss, leading to permanent (non-painful) blindness within a year. annually in the claims dataset for the period of 2018-2021. The Clarivate U.S. real world data set covers 90% of the insured population in all U.S. Our real world data analysis showed a 1.3-fold

Patients 98

Patients Prescription Pharmacology Healthcare 98

PM360

DECEMBER 17, 2023

Farquhar previously served as Chief Marketing Officer at Publicis Media, where he led global assignments in a variety of industry verticals, including telecommunications, pharma, and CPG. In his new role, Farquhar will be responsible for leading Publicis Health businesses in the U.S., and Payer Sciences. and Payer Sciences.

Media 52

Media Healthcare Healthcare Leads 52

pharmaphorum

SEPTEMBER 1, 2022

She will join the Swiss pharma group after stepping down from her current role as senior vice president of discovery, preclinical and translational medicine at Merck, a position she has held since April 2021. " This rings true today as I share news that I will step down as President of NIBR on Oct 31.

Medicine 59

Medicine Biopharma Engineering Pharma 59

pharmaphorum

JULY 27, 2022

In addition, the median time between regulatory approval and the first patient receiving a first dose was 247 days in 2020 – an increase of 25 days since 2018. The LSCIs are critical for measuring the elements of the life science ecosystem that are required to tackle the leading causes of morbidity and mortality in the UK.

Government 98

Government Recruitment Medicine Patients 98

pharmaphorum

JANUARY 18, 2023

German pharma group Bayer has made another play in the digital medical imaging category, buying Blackford Analysis and its artificial intelligence-based platform for radiological assessments. That pressure can lead to diagnostic errors, with a 2018 study suggesting that there are 40 million errors involving imaging worldwide every year.

Medical 59

Medical Pharma Media Sales 59

PM360

SEPTEMBER 30, 2024

In her expanded role, Walsh will oversee agency operations, marketing and communications, and innovation for North America, while continuing to lead the PR, Influence and Social business. BridgeBio Pharma, Inc. Exagen This leading provider of autoimmune testing solutions announced the appointment of Jeffrey G.

Consulting 52

Consulting Leads Healthcare Healthcare 52

Pharma Pathway

SEPTEMBER 12, 2022

HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Eligibility: 2018, 2019, 2020, 2021, 2022 passed outs Only. Qualification: M.Sc (Organic Chemistry, Analytical Chemistry)/ B.Sc/ B.Pharm/ B.Com/ ITI/ Diploma.

Manufacturing 52

Manufacturing Pharmaceutical Leads Pharma 52

pharmaphorum

DECEMBER 9, 2022

Novartis seems to be leading the pack with TNO155, which has advanced to phase 2 testing as a monotherapy and is also in combination studies with adagrasib. The phosphatase enzyme – once deemed “undruggable” – is over-expressed in a number of different solid tumour types.

Medicine 59

Medicine Safety Pharma Leads 59

Veeva

FEBRUARY 6, 2022

According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1. Get stakeholder buy in on the “why”. About Veeva.

Pharma 52

Pharma Medical Consulting Patients 52

pharmaphorum

JANUARY 25, 2023

Inefficiencies in promotion budgets can lead to allocating resources to projects that yield little or no benefits or returns. About the author Susan Hill joined IQVIA in 2018 as part of the acquisition of AHM and is responsible for the customer engagement and commercial compliance technology offerings.

Marketing 98

Marketing Sales Retail Management 98

Pharmaceutical Technology

MARCH 24, 2023

Many pharma companies hold extensive patent protections and have ongoing patent litigation cases. For example, the cost of Humira biosimilars in Denmark decreased by 82% from September 2018 to December 2018. The primary reasons for delayed market entry in the US revolve around patent disputes.

Competition 59

Competition Marketing FDA Physicians 59

Pharma Marketing Network

MAY 6, 2023

This can lead to the proliferation of misinformation and cause confusion among consumers (3). 7/8, 2018, pp. The post The Ethical Challenges for Pharmaceutical Marketers in Using AI to Write Marketing Copy or Creative appeared first on Pharma Marketing Network. 1) Danks, D. “AI AI Ethics: The Importance of Fairness.”

Ethics 52

Ethics Marketing Pharmaceutical Training 52

Pharma Marketing Network

JULY 7, 2021

O’Connor will succeed current President and CEO Laurie Cooke, who will step down for a well-earned retirement after leading the organization since 2006. In 2018, she delivered the keynote at HBA’s Annual Conference with more than 1,000 attendees. “As improvements necessary in the international healthcare ecosystem. Bina added. “I

Healthcare 52

Healthcare Healthcare Networking Leads 52

Pharmaceutical Technology

APRIL 4, 2023

While Scorpion will lead the development of STX-721, Pierre Fabre will handle STX-241. Tagrisso was approved for use as a first-line treatment for metastatic NSCLC with EGFR mutation in April 2018. According to GlobalData’s Pharma Intelligence Centre, Tagrisso is forecasted to have global sales of $8.19 Up to 12.5%

Food and Drug Administration 52

Food and Drug Administration Biopharma FDA Pharmaceutical 52

pharmaphorum

DECEMBER 6, 2022

$500 million upfront and a total deal value of up to $5 billion sounds like a deal made by a top-tier pharma company – but in fact it comes from diminutive biotech Summit Therapeutics.

Patients 52

Patients Pharma Leads Marketing 52

Clarify Health

JULY 13, 2020

The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. Approvals have spiked in recent years, with 59 new drugs approved in 2018.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

PM360

OCTOBER 22, 2024

Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcare providers (HCPs). When patients feel a pharma brand is responsive to their needs and committed to improving their treatment experience, it reinforces that brand’s reputation as a partner in their healthcare journey.³

Patients 59

Patients Healthcare Provider Pharma Prescription 59

Clarivate

APRIL 24, 2023

Pharmacy giants battle to bulk up with provider group buys CVS Health rattled the healthcare industry when it acquired one of the nation’s top insurers, Aetna, in 2018, and the giant retailer continues to make waves. billion deal to acquire Oak Street Health, a value-based primary-care company focused on treating Medicare patients.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

European Pharmaceutical Review

NOVEMBER 30, 2023

For example, the GMP report stated that the contract development and manufacturing organisation (CDMO) eXmoor pharma, will be launching a cell and gene therapy process development and clinical manufacturing facility in Bristol. Licensing of the manufacturing suites is expected in early 2024.

Manufacturing 97

Manufacturing Recruitment Medicine Biopharma 97

PM360

JUNE 11, 2022

Observationally, this is truer for the small and mid-size pharma and biotech companies than for larger pharma companies. s 2018 article ‘The Rules of Engagement,’ which provides a checklist pharmaceutical companies can use to evaluate which patient groups to collaborate with on clinical trials. What Even Is Patient Centricity?

Patients 98

Patients Medical Education Government 98